| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8247336 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 6 Pages |
Abstract
Conclusion: The primary tumor volume as well as TTV is a significant prognostic factor on survival in patients with Stage III NSCLC treated with RT and should be recorded in clinical results when the survivals are compared among clinical studies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kiyoshi M.D., Ph.D., Yoshinao M.D., Ph.D., Masahiko M.D., Ph.D., Hidehiro M.D., Ph.D., Yoshiomi M.D., Shigeyuki M.D., Ph.D.,